Quick Answer
Orthofix Medical Inc. reported Cash and Equivalents of $82.03 million for fiscal year 2025.
Orthofix Medical Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $82.03M | -1.5% |
| 2024 | $83.24M | +151.4% |
| 2023 | $33.11M | -34.7% |
| 2022 | $50.70M | -42.3% |
| 2021 | $87.85M | -8.8% |
| 2020 | $96.29M | +38.1% |
| 2019 | $69.72M | +0.1% |
| 2018 | $69.62M | -14.2% |
| 2017 | $81.16M | +105.1% |
| 2016 | $39.57M | -37.8% |
| 2015 | $63.66M | +72.9% |
| 2014 | $36.81M | +27.3% |
| 2013 | $28.92M | -6.0% |
| 2012 | $30.77M | -6.0% |
| 2011 | $32.74M | +141.4% |
| 2010 | $13.56M | +1.7% |
| 2009 | $13.33M | -8.7% |
| 2008 | $14.59M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $62.86M | +109.2% | -4.2% |
| June 30, 2025 | $65.61M | +148.8% | +13.2% |
| March 31, 2025 | $57.95M | +114.9% | -30.4% |
| December 31, 2024 | $83.24M | +151.4% | +177.0% |
| September 30, 2024 | $30.05M | -10.7% | +14.0% |
| June 30, 2024 | $26.37M | -29.9% | -2.2% |
| March 31, 2024 | $26.96M | -46.0% | -18.6% |
| December 31, 2023 | $33.11M | -34.7% | -1.7% |
- Orthofix Medical Inc. showed a decrease of -1.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, Orthofix Medical Inc.’s cash and equivalents has grown by 462.0% (from $14.59 million to $82.03 million).
- The most recent figure is from Orthofix Medical Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: